Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 14.3194 | 100 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 14.2104 | 100 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 14.2025 | 100 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 14.1736 | 100 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 14.1153 | 100 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 14.3798 | 100 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 14.3011 | 100 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 14.1814 | 100 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 14.19 | 100 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 14.1813 | 100 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 14.3333 | 100 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 14.189 | 100 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 14.2175 | 100 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 14.1043 | 100 |